Sublime

I like $SRPT. It’s trading like it’s some cruddy generics company instead of a growing biotech (<2x revs)

@MartinShkreli @eightyhi @oaktoebark @iabvek He really should be doing that, someone should be funding him on ISDA swaps with banks cause he's the best in the world from what I've seen as has made peanuts with his skill, had to stop trying to make those markets cause he just nailed it every release, really impressive.

@MartinShkreli Meanwhile biotechs with legit good Phase 2 oncology data (MAIA, CADL) languish with tiny market caps.

Martin Shkreli says that Michael Saylor is not a good advocate for Bitcoin and he is shorting $MSTR because “it is going to end badly.” https://t.co/tdruogA2TI

i'm short $ATYR and predict the stock will drop 80% in the next 4 to 6 weeks. some of the worst data i've ever seen. really bad drug, really tough disease. as confident as $SAVA $INMB $GALT etc